Atopic Dermatitis - The Dermatology Digest

AD Pipeline Watch: U.S. FDA Clears IND for Zabalafin Hydrogel in AD

February 19, 2025

Galderma’s Nemolizumab Approved for AD and PN in the UK and Switzerland

February 18, 2025

Beyond Broad Topical and Systemic Immunosuppressants: New Research Highlights Advances in Understanding and Treating AD

February 14, 2025

Galderma Scores Twin Approvals for Nemolizumab in Europe

February 14, 2025

AD Pipeline Watch: U.S. FDA Fast Tracks Nektar Therapeutics’ AD Candidate

February 10, 2025

AD Pipeline Watch: First Patient Dosed in Part B of Phase 2 APEX Trial of Apogee’s APG777 in Moderate-to-Severe AD

February 3, 2025

Advertisement

Latest Issue

Latest Supplements

Advertisement

Digital Edition Archive